Discovery of a series of potent arylthiadiazole H(3) antagonists.

Bioorg Med Chem Lett

Chemical Research Department, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07033, United States.

Published: January 2011

A series of 2-piperidinopiperidine-5-arylthiadiazoles was synthesized and subjected to a structure-activity relationship (SAR) investigation. The potency of this series was improved to the single digit nanomolar range. The key analogs were shown to be free of P450 issues, and they also maintained good ex vivo activity and brain penetration.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.11.065DOI Listing

Publication Analysis

Top Keywords

discovery series
4
series potent
4
potent arylthiadiazole
4
arylthiadiazole antagonists
4
antagonists series
4
series 2-piperidinopiperidine-5-arylthiadiazoles
4
2-piperidinopiperidine-5-arylthiadiazoles synthesized
4
synthesized subjected
4
subjected structure-activity
4
structure-activity relationship
4

Similar Publications

Rearranged during transfection (RET) kinase is a validated therapeutic target for various cancers characterized by RET alterations. Although two selective RET inhibitors, selpercatinib and pralsetinib, have been approved by the FDA, acquired resistance through solvent-front mutations has been identified rapidly. Developing proteolysis targeting chimera (PROTAC) targeting RET mutations offers a promising strategy to combat drug resistance.

View Article and Find Full Text PDF

Carrageenans have attracted increasing research interests in recent decades for their various physicochemical and physiological properties. Random endo-acting carrageenases are promising tools for tailoring the molecular weight of carrageenan and preparing a series of carrageenan oligosaccharides. Although the processive ι-carrageenases in the GH82 family have been widely investigated, the random ι-carrageenase has not been reported.

View Article and Find Full Text PDF

Effects of Acute Stress on Metabolic Interactions Related to the Tricarboxylic Acid (TCA) Cycle in the Left Hippocampus of Mice.

Metabolites

December 2024

Department of Radiation Convergence Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, 1, Yeonsedae-gil, Heungeop-myeon, Wonju 26493, Republic of Korea.

Background/objectives: The acute stress response affects brain metabolites closely linked to the tricarboxylic acid (TCA) cycle. This response involves time-dependent changes in hormones and neurotransmitters, which contribute to resilience and the ability to adapt to acute stress while maintaining homeostasis. This physiological mechanism of metabolic dynamics, combined with time-series analysis, has prompted the development of new methods to observe the relationship between TCA cycle-related brain metabolites.

View Article and Find Full Text PDF

Background/objectives: Anterior Gradient-2 (AGR2/PDIA17) is a member of the protein disulfide isomerase (PDI) family of oxidoreductases. AGR2 is up-regulated in several solid tumors, including pancreatic ductal adenocarcinoma (PDAC). Given the dire need for new therapeutic options for PDAC patients, we investigated the expression and function of AGR2 in PDAC and developed a novel series of affinity-matured AGR2-specific single-chain variable fragments (scFvs) and monoclonal antibodies.

View Article and Find Full Text PDF

Introduction: Modifiable Areal Unit Problems are a major source of spatial uncertainty, but their impact on infectious diseases and epidemic detection is unknown.

Methods: CMS claims (2016-2019) which included infectious disease codes learned through Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) were extracted and analysed at two different units of geography; states and 'home to work commute extent' mega regions. Analysis was per member per month.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!